- Text-only version of this website
- Skip navigation
- Home page
- What's new
- Contact Webmaster
- Website policies
- Disability services
The Centers for Medicare and Medicaid Services criteria are used to flag high-risk patients for opioid abuse and overdose.
The distinction comes with a two-year, $104,000 award, which Vouri will use to study a type of drug-induced adverse event called a prescribing cascade in older adults.
“Current policies to limit opioid prescriptions leave some pain patients high and dry, resulting in a new wave of unintended consequences for patients with untreated chronic pain.”
The center will unite researchers interested in using big data to evaluate drugs and the safety of medications in real-world populations.
The study, published in the journal Hepatology, examined the clinical and economic outcomes of direct-acting antiviral therapy, which cures hepatitis C in nearly 95 percent of patients.
The Department of Pharmaceutical Outcomes & Policy is proud to announce that Yan Li was the winner of the 2019 poster competition in the category of “Pain, Addiction, and CNS […]